Goldman Sachs Group Inc Cytosorbents Corp Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 46,796 shares of CTSO stock, worth $42,584. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,796
Previous 62,662
25.32%
Holding current value
$42,584
Previous $62,000
4.84%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CTSO
# of Institutions
52Shares Held
16.7MCall Options Held
28.9KPut Options Held
0-
Avenir Corp Washington, DC5.06MShares$4.6 Million0.7% of portfolio
-
Skylands Capital, LLC2.62MShares$2.38 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$1.93 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.59MShares$1.45 Million0.0% of portfolio
-
Cm Management, LLC1.25MShares$1.14 Million1.64% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $39.7M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...